Medication info
Rabeprazole Sodium 10 mg (Rabeprazole Sodium)

Rabeprazole Sodium 10 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Independent Bio Pharmaceutical Co., Ltd.
Appearance
Light yellow round enteric-coated tablets
Packaging
28T (14T/1PTP X 2 EA)
Approval status
Active

MFDS item code 201905355 · Approved 2019.07.29

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination for eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Symptom relief for gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg/day according to each patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. ◯ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ◯ Older adults Administer with caution, as hepatic function is often impaired.

Ingredients

Manufacturer
Independent Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination for eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastric ulcers and duodenal ulcers. It also relieves symptoms of erosive or ulcerative gastroesophageal reflux disease and is effective in long-term maintenance therapy of gastroesophageal reflux disease. In patients with Helicobacter pylori infected gastrointestinal ulcers, it is combined with antibiotics for treatment. Additionally, it helps manage diseases related to excessive gastric acid secretion, such as Zollinger-Ellison syndrome. Overall, it is used for the treatment of gastrointestinal ulcers and diseases related to gastroesophageal conditions.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Symptom relief for gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg/day according to each patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. ◯ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ◯ Older adults Administer with caution, as hepatic function is often impaired.

Precautions

This medication should not be used in patients with allergies to certain drugs or components. Caution is needed when administering to patients allergic to penicillin or macrolide antibiotics. It is safest for pregnant or breastfeeding women to avoid taking this medication. Patients with impaired liver function or the elderly should use this medication cautiously and consult a doctor immediately if any abnormal symptoms occur. This medication may cause allergic reactions such as skin rash, itching, and hives, and should be discontinued if symptoms occur. It is important to have regular blood tests or liver function tests to monitor for any abnormalities. Various side effects may occur in different areas, including the heart, gastrointestinal, and nervous system, so patients should be vigilant about symptoms. This medication suppresses gastric acid secretion, which may increase the risk of fractures with long-term use, requiring periodic examinations. Furthermore, long-term use may lead to hypomagnesemia, necessitating monitoring of magnesium levels. If gastrointestinal infection symptoms such as diarrhea persist during use, immediate consultation with medical staff is advised. Caution is needed as drowsiness may occur while driving or operating machinery. This medication may interact with other drugs, so it is essential to inform about any concomitant medications. Special caution is needed when used with antiviral agents or some antibiotics. This medication should be swallowed whole without chewing or crushing. Keep out of reach of children and do not transfer to other containers. It is safest to avoid this medication during pregnancy or breastfeeding. Safety in pediatric patients has not been established, so usage requires caution. There is no specific antidote for overdose, so appropriate treatment should be provided based on symptoms. It is important to conduct regular examinations to check for side effects in cases of long-term use.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, ALT elevation, AST elevation, ALP elevation, γ-GTP elevation, LDH elevation, total bilirubin elevation, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, ECG abnormality, migraine, syncope, angina pectoris, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, hyperphagia, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, polydipsia, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disturbances, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenopathy, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, upper and lower limb weakness, sensory impairment, decreased grip strength, language confusion, staggering, delirium, disorientation, narcolepsy, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonia, neuralgia, single contraction, sweating, alopecia, skin dryness, herpes zoster, psoriasis, skin pigmentation changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequency of urination, dysmenorrhea, urinary difficulty, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, total cholesterol elevation, triglycerides elevation, BUN elevation, serum thyroid-stimulating hormone elevation, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, anorexia, cervical rigidity, phototoxic reaction, hangover effect, weight loss, gout, anaphylaxis, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, disorientation, delirium, vascular edema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, myalgia, arthralgia, interstitial nephritis, gynecomastia, thyroid-stimulating hormone elevation, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, INR elevation, prothrombin time elevation, bone fractures, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, discoid lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and humidity, so it must be stored in a tightly sealed container. It is recommended to maintain storage at room temperature between 1°C and 30°C. Proper storage will help prolong the efficacy of the medication.

Appearance and packaging

Appearance

Light yellow round enteric-coated tablets

Package unit

28T (14T/1PTP X 2 EA)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.